Early prediction and mechanism of the Ribavirin/IFN-α dual therapy effect on chronic hepatitis C virus (HCV) infection.

被引：0
|
作者：
Neumann, AU
Dahari, H
Conrad, A
Pianko, S
McHutchinson, JG
机构：
[1] Bar Ilan Univ, Ramat Gan, Israel
[2] Natl Inst Genet, Los Angeles, CA USA
[3] Scripps Clin, La Jolla, CA USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
595
引用
收藏
页码：309A / 309A
页数：1
相关论文
共 50 条
  • [11] Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection
    Tang, L.
    Ward, H.
    Kattakuzhy, S.
    Wilson, E.
    Kottilil, S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (01) : 21 - 36
  • [12] Peg-IFN-α plus ribavirin combined therapy restores circulating IFN-α-producing dendritic cells in patients with chronic hepatitis C virus infection
    Riva, A
    Della Bella, S
    Benetti, A
    Crosignani, A
    Brambilla, G
    Memoli, M
    Villa, ML
    JOURNAL OF HEPATOLOGY, 2005, 42 : 218 - 218
  • [13] RIBAVIRIN PRETREATMENT IMPROVES THE IFN-γ RESPONSE OF NATURAL KILLER CELLS TO IFN-BASED THERAPY OF HEPATITIS C VIRUS INFECTION
    Werner, J. M.
    Serti, E.
    Chepa-Lotrea, X.
    Ahlenstiel, G.
    Feld, J.
    Liang, T. J.
    Rehermann, B.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S117 - S117
  • [14] A pilot study of amantadine and ribavirin therapy in those with chronic hepatitis C infection.
    Riley, TR
    Mathew, A
    Smith, JP
    HEPATOLOGY, 2002, 36 (04) : 573A - 573A
  • [15] Minimal change disease in a patient receiving IFN-α therapy for chronic hepatitis C virus infection
    Dizer, U
    Beker, CM
    Yavuz, I
    Ortatatli, M
    Ozguven, V
    Pahsa, A
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2003, 23 (01): : 51 - 54
  • [16] Evaluation of HFE mutations in patients with chronic hepatitis C virus (HCV) infection.
    Halangk, J
    Witt, H
    Puhl, G
    Gäbelein, G
    Müller, T
    Landt, F
    Neuhaus, P
    Wiedenmann, B
    Luck, W
    Berg, T
    HEPATOLOGY, 2004, 40 (04) : 683A - 683A
  • [17] GM-CSF may modulate the response to therapeutic IFN-α in chronic hepatitis C virus (HCV) infection
    Tajuddin, Tariq
    Ryan, Elizabeth
    Hegarty, John
    O'Farrelly, Cliona
    HEPATOLOGY, 2007, 46 (04) : 387A - 387A
  • [18] The clinical significance of intrahepatic hepatitis C virus (HCV) levels in patients with chronic HCV infection.
    Haydon, GH
    Jarvis, LM
    Hayes, PC
    Harrison, DJ
    HEPATOLOGY, 1996, 24 (04) : 1041 - 1041
  • [19] Immunoglobulin allotypes and hepatitis C virus (HCV) infection.
    Rat, C
    Goria, O
    Doffoel, M
    Vinel, JP
    Daveau, M
    Dugoujon, JM
    Lerebours, E
    GASTROENTEROLOGY, 1998, 114 (04) : A1326 - A1326
  • [20] Ribavirin treatment for immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
    Jaccard, A
    Loustaud, V
    Touati, M
    Vidal, E
    Bordessoule, D
    BLOOD, 2002, 100 (11) : 306B - 306B
12345